People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Biotechnology, Healthtech, Pharmaceuticals, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Selecta Biosciences Inc | — | Biotechnology | Series D+ | $445.6M | $1.4B | 2010 |
| Rubius Therapeutics, Inc. | — | Biotechnology | Series D+ | $216.2M | $4.2B | 2017 |
| Suneva Medical, Inc. | — | Healthtech | Series B | $140.2M | $24.9M | 2015 |
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.7M | 2011 |
| Seres Health, Inc. | — | Pharmaceuticals | Series C | $123.6M | $2.3B | 2014 |
| Axcella Health Inc. | — | Biotechnology | Series C | $92.8M | $105.4M | 2015 |
| BIND Biosciences Inc | — | Biotechnology | Series B | $51.4M | $345.2M | 2010 |
| Living Proof Inc | — | Other | Series B | $39.0M | $498.4M | 2013 |
| Salarius Pharmaceuticals, Inc. | — | Biotechnology | Series B | $34.6M | $57.7M | 2014 |
| Cerehealth Corp | — | Other Health Care | Series A | $13.9M | $38.9M | 2019 |
| Whole Biome Inc. | — | Biotechnology | Series A | $10.5M | $379.6M | 2017 |
| CoLabs Int'l, Corp. | — | Pharmaceuticals | Seed | $6.4M | $3.1M | 2013 |
| Q Holdings, Inc. | — | Biotechnology | Series A | $4.0M | $145.3M | 2011 |
| Atelerix Life Sciences Inc. | — | Biotechnology | Pre-Seed | $650K | $9.1M | 2022 |
Peter Barton Hutt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Barton Hutt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert S Langer | 4 | 14 |
| Noubar Afeyan | 3 | 9 |
| Omid Farokhzad | 3 | 4 |
| Omid C. Farokhzad | 3 | 3 |
| Robert S. Langer, Jr. | 3 | 3 |
| Werner Cautreels | 2 | 5 |
| Amir H. Nashat | 2 | 3 |
| David Berry | 2 | 3 |
| Aymeric S. Sallin | 2 | 2 |
| Robert Langer | 1 | 36 |
| Carl Gordon | 1 | 24 |
| Brian Chee | 1 | 10 |
| James Wright | 1 | 9 |
| Christoph Westphal | 1 | 8 |
| CARL L. GORDON | 1 | 7 |
| Brian Roberts | 1 | 7 |
| Scott Minick | 1 | 7 |
| Robert Crane | 1 | 7 |
| Jonathan Flint | 1 | 6 |
| James Barrett | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.